Genmab CEO interview video: <A HREF="http://www.thestreet.com/video/todaysvid.." target="_blank">http://www.thestreet.com/video/todaysvid..</A>. Interesting comments re Genmab's CD20 fully human monoclonal antibody vis a vis Rituxan, among other things.